Absorbed doses in humans from 188 Re-Rituximab in the free form and bound to superparamagnetic iron oxide nanoparticles: Biodistribution study in mice-Reference-Cited by-同舟云学术

Absorbed doses in humans from 188 Re-Rituximab in the free form and bound to superparamagnetic iron oxide nanoparticles: Biodistribution study in mice

Published:2018-01 Issue: Volume:131 Page:96-102
ISSN:0969-8043
Container-title:Applied Radiation and Isotopes
language:en
Short-container-title:Applied Radiation and Isotopes

Author:

Azadbakht Bakhtiar,Afarideh Hossein,Ghannadi-Maragheh Mohammad,Bahrami-Samani Ali,Yousefnia Hassan

Publisher

Elsevier BV

Subject

Radiation

Reference48 articles.

1. Development of an electrochemical 188W/188Re generator as a technique for separation and purification of 188Re in radiopharmaceutical applications;Azadbakht;Appl. Radiat. Isot.,2016

2. Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to Rhenium-188 labeled Rituximab;Azadbakht;Nucl. Med. Biol.,2016

3. Internal dosimetry primer;Bevelacqua;Radiat. Prot. Manag.,2005

4. Guidelines on the Use of Living Animals in Scientific Investigations;Biological Council,1987

5. Effective dose: a flawed concept that could and should be replaced;Brenner;Br. J. Radiol.,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical studies and absorbed dose estimation of [89Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumors;Applied Radiation and Isotopes;2024-08

2. Determination of the Re-188 Calibration Number for the Capintec CRC- 25PET Dose Calibrator;Current Radiopharmaceuticals;2023-12

3. Exploring the Potential of Zirconium-89 in Diagnostic Radiopharmaceutical Applications: An Analytical Investigation;Biomedicines;2023-04-13

4. Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with 44Sc and 47Sc for Theranostic Application;Pharmaceutics;2023-03-05

5. Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles;Advanced Drug Delivery Reviews;2023-03